Study Combining Brain MRI Findings and Latest RNA Sequencing Technology to Identify Drugs for Preventing Post-COVID Cognitive Impairment
|
By HospiMedica International staff writers Posted on 07 Sep 2021 |
|
Image: Study Combining Brain MRI Findings and Latest RNA Sequencing Technology to Identify Drugs for Preventing Post-COVID Cognitive Impairment (Photo courtesy of John Emerson)
A new study will examine how COVID-19 is affecting individuals in a number of cognitive-related areas, including memory loss, “brain fog,” and dementia.
Scientists at Rutgers University (New Brunswick, NJ, USA) are spearheading the characterization of cognitive impairment following mild-to-moderate COVID-19. The team will assess each person’s cognition, mood, and sleep patterns to identify potential causes of brain fog and compare their brain MRI findings with biochemical signatures of neuroinflammation. They will analyze microglial cells - critically important immune cells in the brain - from individuals who have had COVID-19 to determine whether those cells can be used to predict the persistence of post-COVID cognitive impairment (PCCI). This will allow researchers to begin to generate new hypotheses on why these cells may dysfunction in COVID-19 and PCCI, what the shared inflammatory mechanisms are between PCCI and Alzheimer’s disease, and whether FDA-approved drugs can be repurposed to prevent the onset of PCCI or improve its outcomes
“Many people who recover from mild or moderate COVID-19 notice slowed thinking or memory loss, and this motivated us to leverage our experience in studying cognitive issues related to Alzheimer’s disease, multiple sclerosis, and HIV to examine this phenomenon,” said Dr. William T. Hu, associate professor and chief of cognitive neurology at Rutgers Robert Wood Johnson Medical School and the Institute for Health, Health Care Policy, and Aging Research, who is leading the study.
“We have found neuroinflammation is a common theme across many brain disorders, but not all neuroinflammation is the same,” he noted. “We developed a roadmap to study the protein and cellular changes involved in worsening - as well as alleviating - symptoms of brain fog. In addition, we are using the latest RNA sequencing technology to understand how inflammatory cells ‘misbehave’ to cause memory/thinking dysfunction in long COVID.”
Related Links:
Rutgers University
Scientists at Rutgers University (New Brunswick, NJ, USA) are spearheading the characterization of cognitive impairment following mild-to-moderate COVID-19. The team will assess each person’s cognition, mood, and sleep patterns to identify potential causes of brain fog and compare their brain MRI findings with biochemical signatures of neuroinflammation. They will analyze microglial cells - critically important immune cells in the brain - from individuals who have had COVID-19 to determine whether those cells can be used to predict the persistence of post-COVID cognitive impairment (PCCI). This will allow researchers to begin to generate new hypotheses on why these cells may dysfunction in COVID-19 and PCCI, what the shared inflammatory mechanisms are between PCCI and Alzheimer’s disease, and whether FDA-approved drugs can be repurposed to prevent the onset of PCCI or improve its outcomes
“Many people who recover from mild or moderate COVID-19 notice slowed thinking or memory loss, and this motivated us to leverage our experience in studying cognitive issues related to Alzheimer’s disease, multiple sclerosis, and HIV to examine this phenomenon,” said Dr. William T. Hu, associate professor and chief of cognitive neurology at Rutgers Robert Wood Johnson Medical School and the Institute for Health, Health Care Policy, and Aging Research, who is leading the study.
“We have found neuroinflammation is a common theme across many brain disorders, but not all neuroinflammation is the same,” he noted. “We developed a roadmap to study the protein and cellular changes involved in worsening - as well as alleviating - symptoms of brain fog. In addition, we are using the latest RNA sequencing technology to understand how inflammatory cells ‘misbehave’ to cause memory/thinking dysfunction in long COVID.”
Related Links:
Rutgers University
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Enteral Feeding Pump
Instilar 1420
New
Multifunctional Patient Floor Lift
Maxi Move 5
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Critical Care
view channel
AI Interpretability Tool for Photographed ECG Images Offers Pixel-Level Precision
The electrocardiogram (ECG) is a crucial diagnostic tool in modern medicine, used to detect heart conditions such as arrhythmias and structural abnormalities. Every year, millions of ECGs are performed... Read more
AI-ECG Tools Can Identify Heart Muscle Weakness in Women Before Pregnancy
Each year, some mothers die from heart-related issues after childbirth, with many of these deaths being preventable. Screening for heart weakness before pregnancy could be crucial in identifying women... Read more
Surgical Techniques
view channel
Early TAVR Intervention Reduces Cardiovascular Events in Asymptomatic Aortic Stenosis Patients
Each year, approximately 300,000 Americans are diagnosed with aortic stenosis (AS), a serious condition that results from the narrowing or blockage of the aortic valve in the heart. Two common treatments... Read more
New Procedure Found Safe and Effective for Patients Undergoing Transcatheter Mitral Valve Replacement
In the United States, approximately four million people suffer from mitral valve regurgitation, the most common type of heart valve disease. As an alternative to open-heart surgery, transcatheter mitral... Read more
No-Touch Vein Harvesting Reduces Graft Failure Risk for Heart Bypass Patients
A coronary artery bypass graft (CABG) is a surgical procedure used to enhance blood flow and oxygen supply to the heart in individuals with coronary heart disease. During the procedure, a healthy blood... Read more
DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more
